Device Week – European Edition
This article was originally published in The Gray Sheet
On this week's podcast, Amanda Maxwell, London-based medtech regulatory affairs editor for Clinica, provides an update and important context on the ongoing effort to significantly reform device and diagnostics oversight in the European Union. Clinica is a sister publication to "The Gray Sheet."
You may also be interested in...
UCB's R&D efforts include late-stage diverse but complementary immunologicals and anti-neuroinflammatories.
Janssen and AstraZeneca are among a raft of companies that might this week find out whether the European Medicines Agency will recommend approval of their products for expanded therapeutic indications.
Shares in Iovance Biotherapeutics have soared this week amid reports the US clinical-stage biotechnology company is in active M&A talks.